Clinical Trials Logo

Viral Infection clinical trials

View clinical trials related to Viral Infection.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04401410 Terminated - SARS-CoV 2 Clinical Trials

Anti-SARS Cov-2 T Cell Infusions for COVID 19

BATIT
Start date: November 4, 2020
Phase: Phase 1
Study type: Interventional

This is a dose-finding safety trial followed by a randomized pilot trial comparing administration of SARS-CoV2-specific T cells (SARS-CoVSTs) to standard of care treatment in hospitalized patients with COVID19 who are at high risk of requiring mechanical ventilation. The SARS-CoVSTs lines have been made at Baylor College of Medicine from healthy donors who have made a full recovery from COVID19. These cell lines were frozen for later use and will be thawed and used to treat patients who meet the eligibility criteria.

NCT ID: NCT02696291 Terminated - Viral Infection Clinical Trials

Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy Subjects

Start date: May 27, 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and pharmacokinetics of UV-4B oral solution when administered to healthy subjects three times a day (TID) for 7 days.

NCT ID: NCT00952185 Terminated - Lymphoma Clinical Trials

Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers

Start date: November 2008
Phase: N/A
Study type: Interventional

RATIONALE: The influenza vaccine may help prevent flu in patients who have undergone stem cell transplant. PURPOSE: This clinical trial is studying how well the influenza vaccine works in preventing flu in patients who have undergone stem cell transplant and in healthy volunteers.